Dr. Spillman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St 793
Little Rock, AR 72205Phone+1 501-686-5827Fax+1 501-686-8091
Education & Training
- Duke University HospitalFellowship, Gynecologic Oncology, 2003 - 2006
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1999 - 2003
- University of Texas Southwestern Medical SchoolClass of 1999
Certifications & Licensure
- TX State Medical License 2009 - 2026
- AR State Medical License 2023 - 2025
- CO State Medical License 2006 - 2015
- NC State Medical License 2003 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy Start of enrollment: 2010 Feb 01
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 182 citationsDNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.Christopher Korch, Monique A. Spillman, Twila A. Jackson, Britta M. Jacobsen, Susan K. Murphy
Gynecologic Oncology. 2012-10-01 - 575 citationsIdentification of a RING protein that can interact in vivo with the BRCA1 gene product.Leeju C. Wu, Zhuo Wei Wang, Julia Tsou Tsan, Monique A. Spillman, Anne Phung
Nature Genetics. 1996-12-01 - 52 citationsTissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.Monique A. Spillman, Nicole G. Manning, Wendy W. Dye, Carol A. Sartorius, Miriam D. Post
Cancer Research. 2010-11-01
Journal Articles
- CBX2 Identified as Driver of Anoikis Escape and Dissemination in High Grade Serous Ovarian CancerMonique A Spillman, Kian Behbakht, Miriam D Post, Amber A Berning, Nature
Press Mentions
- What Doctors Wish Patients Knew About Inflammatory Bowel DiseaseJanuary 6th, 2023
- Gynecologic Cancer Clinicians and Researchers Recognized at SGO 2022 Annual Meeting on Women’s CancerMarch 21st, 2022
- Cancer Mortality Rates Reach Record LowFebruary 7th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: